(Q45347575)

13 December 2017

Confirmatory analysis for phase III population pharmacokinetics (English)

1 reference

13 December 2017

1 reference

Chuanpu Hu

1

1 reference

PubMed ID

20041468

13 December 2017

Ji Zhang

series ordinal

2

1 reference

PubMed ID

20041468

13 December 2017

Honghui Zhou

series ordinal

3

1 reference

13 December 2017

1 January 2011

1 reference

Pharmaceutical Statistics

13 December 2017

1 reference

13 December 2017

10

1 reference

13 December 2017

14-26

1 reference

13 December 2017

1

1 reference

Population-based assessments of clinical drug-drug interactions: qualitative indices or quantitative measures?

13 December 2017

1 reference

A regulatory perspective on pharmacokinetic/pharmacodynamic modelling

21 January 2018

1 reference

Estimating the predictive quality of dose-response after model selection

21 January 2018

1 reference

The lasso--a novel method for predictive covariate model building in nonlinear mixed effects models.

21 January 2018

1 reference

Efficient screening of covariates in population models using Wald's approximation to the likelihood ratio test

21 January 2018

1 reference

Development and evaluation of a population pharmacokinetic-pharmacodynamic model of darbepoetin alfa in patients with nonmyeloid malignancies undergoing multicycle chemotherapy

21 January 2018

1 reference

Learning versus confirming in clinical drug development

21 January 2018

1 reference

Quantitative disease, drug, and trial models

21 January 2018

1 reference

Design evaluation for a population pharmacokinetic study using clinical trial simulations: a case study.

21 January 2018

1 reference

A general model for the origin of allometric scaling laws in biology

21 January 2018

1 reference

The fourth dimension of life: fractal geometry and allometric scaling of organisms.

21 January 2018

1 reference

Paracetamol and metabolite pharmacokinetics in infants.

21 January 2018

1 reference

Comment on "The illusion of invariant quantities in life histories".

21 January 2018

1 reference

Human renal function maturation: a quantitative description using weight and postmenstrual age.

21 January 2018

1 reference

Effects of size and temperature on metabolic rate

21 January 2018

1 reference

Developmental pharmacokinetics of morphine and its metabolites in neonates, infants and young children.

21 January 2018

1 reference

Acetaminophen developmental pharmacokinetics in premature neonates and infants: a pooled population analysis

21 January 2018

1 reference

Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance

21 January 2018

1 reference

Mechanism-based concepts of size and maturity in pharmacokinetics

21 January 2018

1 reference

Morphine pharmacokinetics and pharmacodynamics in preterm and term neonates: secondary results from the NEOPAIN trial

21 January 2018

1 reference

The impact of misspecification of residual error or correlation structure on the type I error rate for covariate inclusion.

21 January 2018

1 reference

Model-based drug development

21 January 2018

1 reference

Pharmacometrics at FDA: evolution and impact on decisions

21 January 2018

1 reference

Design in nonlinear mixed effects models: optimization using the Fedorov-Wynn algorithm and power of the Wald test for binary covariates

21 January 2018

1 reference

The predominance of quarter-power scaling in biology

21 January 2018

1 reference

Mixed-Effects Models in Sand S-PLUS

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PST.403

1 reference

13 December 2017

1 reference

PubMed ID

20041468